Translational medicine for acute lung injury

被引：0
作者：
Jianguo Zhang
Yumeng Guo
Michael Mak
Zhimin Tao
机构：
[1] Jiangsu University,Department of Emergency Medicine, The Affiliated Hospital
[2] Jiangsu University,Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, Department of Laboratory Medicine, School of Medicine
[3] Yale University,Department of Biomedical Engineering, School of Engineering and Applied Science
[4] Jiangsu University,Zhenjiang Key Laboratory of High Technology Research on Exosomes Foundation and Transformation Application, School of Medicine
来源：
Journal of Translational Medicine | / 22卷
关键词：
Acute lung injury; Acute respiratory distress syndrome; Animal model; Nanomedicine; Drug delivery; Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Acute lung injury (ALI) is a complex disease with numerous causes. This review begins with a discussion of disease development from direct or indirect pulmonary insults, as well as varied pathogenesis. The heterogeneous nature of ALI is then elaborated upon, including its epidemiology, clinical manifestations, potential biomarkers, and genetic contributions. Although no medication is currently approved for this devastating illness, supportive care and pharmacological intervention for ALI treatment are summarized, followed by an assessment of the pathophysiological gap between human ALI and animal models. Lastly, current research progress on advanced nanomedicines for ALI therapeutics in preclinical and clinical settings is reviewed, demonstrating new opportunities towards developing an effective treatment for ALI.
引用
收藏
相关论文
共 1159 条
[11]  
Itenov T(2016)The presence of diffuse alveolar damage on open lung biopsy is associated with mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis Chest 149 1155-800
[12]  
Sivapalan P(2013)Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy Am J Respir Crit Care Med 187 761-81
[13]  
Eklöf J(2019)Respiratory mechanics, lung recruitability, and gas exchange in pulmonary and extrapulmonary acute respiratory distress syndrome Crit Care Med 47 792-380
[14]  
Holm F(1994)Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. consensus committee J Crit Care 9 72-713
[15]  
Schuetz P(2012)Acute respiratory distress syndrome: the Berlin definition JAMA 307 2526-637
[16]  
Jensen J(2019)Formal guidelines: management of acute respiratory distress syndrome Ann Intensive Care 9 69-1609
[17]  
Matthay MA(2019)Guidelines on the management of acute respiratory distress syndrome BMJ Open Respir Res 6 788-892
[18]  
Zemans RL(2016)Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries JAMA 315 475-710
[19]  
Zimmerman GA(2020)Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Lancet Respir Med. 8 374-1984
[20]  
Arabi YM(2003)Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome JAMA 290 708-1975
12345678910